Improving clinical cognitive testing
Report of the AAN Behavioral Neurology Section Workgroup
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To evaluate the evidence basis of single-domain cognitive tests frequently used by behavioral neurologists in an effort to improve the quality of clinical cognitive assessment.
Methods: Behavioral Neurology Section members of the American Academy of Neurology were surveyed about how they conduct clinical cognitive testing, with a particular focus on the Neurobehavioral Status Exam (NBSE). In contrast to general screening cognitive tests, an NBSE consists of tests of individual cognitive domains (e.g., memory or language) that provide a more comprehensive diagnostic assessment. Workgroups for each of 5 cognitive domains (attention, executive function, memory, language, and spatial cognition) conducted evidence-based reviews of frequently used tests. Reviews focused on suitability for office-based clinical practice, including test administration time, accessibility of normative data, disease populations studied, and availability in the public domain.
Results: Demographic and clinical practice data were obtained from 200 respondents who reported using a wide range of cognitive tests. Based on survey data and ancillary information, between 5 and 15 tests in each cognitive domain were reviewed. Within each domain, several tests are highlighted as being well-suited for an NBSE.
Conclusions: We identified frequently used single-domain cognitive tests that are suitable for an NBSE to help make informed choices about clinical cognitive assessment. Some frequently used tests have limited normative data or have not been well-studied in common neurologic disorders. Utilizing standardized cognitive tests, particularly those with normative data based on the individual's age and educational level, can enhance the rigor and utility of clinical cognitive assessment.
GLOSSARY
- AAN=
- American Academy of Neurology;
- AD=
- Alzheimer disease;
- BIT=
- Behavioral Inattention Test;
- BNS=
- Behavioral Neurology Section;
- BNT=
- Boston Naming Test;
- CERAD=
- Consortium to Establish a Registry in Alzheimer's Disease;
- FAB=
- Frontal Assessment Battery;
- FTLD=
- frontotemporal lobar degeneration;
- HVLT-R=
- Hopkins Verbal Learning Test–Revised;
- JLO=
- Judgment of Line Orientation;
- MMSE=
- Mini-Mental State Examination;
- MoCA=
- Montreal Cognitive Assessment;
- NBSE=
- Neurobehavioral Status Exam;
- ROCFT=
- Rey-Osterrieth Complex Figures Test;
- TBI=
- traumatic brain injury;
- TMT=
- Trail Making Test;
- UCNS=
- United Council for Neurologic Subspecialties;
- WAB-R=
- Western Aphasia Battery–Revised
Footnotes
↵* These authors contributed equally to this work.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received December 2, 2014.
- Accepted in final form May 7, 2015.
- © 2015 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cognitive profile of patients with newly diagnosed Parkinson diseaseDino Muslimović, Bart Post, Johannes D. Speelman et al.Neurology, October 24, 2005 -
Articles
Subscores of the FAB differentiate frontotemporal lobar degeneration from ADA. M. Lipton, K. A. Ohman, K. B. Womack et al.Neurology, September 12, 2005 -
Article
Cognitive heterogeneity in probable Alzheimer diseaseClinical and neuropathologic featuresYuqi Qiu, Diane M. Jacobs, Karen Messer et al.Neurology, July 18, 2019 -
Articles
The MoCAWell-suited screen for cognitive impairment in Parkinson diseaseJ.C. Dalrymple-Alford, M.R. MacAskill, C.T. Nakas et al.Neurology, November 08, 2010